A study of a smallpox vaccine that could prove vital in the United States' war on bioterrorism is under way at Stanford Medical Center. The trial tests the potency of the Dryvax vaccine, a 1970s-era ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback